Health and Fitness Health and Fitness
Mon, August 9, 2010
[ Mon, Aug 09th 2010 ] - Market Wire
Alnylam Scientists and Collaborators Report Significant New Advances in RNAi Delivery
[ Mon, Aug 09th 2010 ] - Market Wire
Clinical Data, Inc. Reports First Quarter Fiscal Year 2011 Operational and Financial Results
[ Mon, Aug 09th 2010 ] - Market Wire
GTx, Inc. Reports Second Quarter 2010 Corporate Results
[ Mon, Aug 09th 2010 ] - Market Wire
WellCare Announces Securities Class Action Settlement
Fri, August 6, 2010
[ Fri, Aug 06th 2010 ] - Market Wire
Biogen Idec, Eastman Kodak, Morgan Stanley, Goldman Sachs and Allstate Corporation
[ Fri, Aug 06th 2010 ] - Market Wire
Chemed Corporation Increases Quarterly Dividend
[ Fri, Aug 06th 2010 ] - Market Wire
Spectral Molecular Imaging Inc. Chief Executive Officer Featured as a Guest on MoneyTV This Week
[ Fri, Aug 06th 2010 ] - Market Wire
Lannett Receives FDA Approval for Ondansetron Injection USP, 2 mg/mL Single-Dose Vials
[ Fri, Aug 06th 2010 ] - Market Wire
Medtronic Completes Enrollment in Clinical Study of Complete SE® (Self-Expanding) Vascular Stent
[ Fri, Aug 06th 2010 ] - Market Wire
El sistema PureGrafta" de Cytori recibe la aproba .. los procedimientos de injertos de tejido adiposo
[ Fri, Aug 06th 2010 ] - Market Wire
Das PureGrafta"-System von Cytori erhlt europische Zulassung fr Fetttransplantationsverfahren
[ Fri, Aug 06th 2010 ] - Market Wire
Il sistema PureGrafta" di Cytori riceve l'approva .. one europea per le procedure di innesto di grasso
[ Fri, Aug 06th 2010 ] - Market Wire
Health Net Federal Services Sponsors AMVETS 2010 Symposium for 21st Century Veterans
[ Fri, Aug 06th 2010 ] - Market Wire
Opexa Therapeutics Reports Second Quarter 2010 Financial Results
[ Fri, Aug 06th 2010 ] - Market Wire
Labopharm to present at Canaccord Genuity 30th Annual Growth Conference
[ Fri, Aug 06th 2010 ] - Market Wire
Notice of Medical Facilities Corporation';s Fisca .. Second Quarter Financial Results Conference Call
[ Fri, Aug 06th 2010 ] - Market Wire
Emeritus and Blackstone Joint Venture Acquires 132 Sunwest Communities
[ Fri, Aug 06th 2010 ] - Market Wire
UnitedHealth Group Announces New Initiatives to E .. an Adoption of EHRs That Meet Federal aMeaningful
[ Fri, Aug 06th 2010 ] - Market Wire
First Patient Treated with Medtronica?s Valiant® Thoracic Stent Graft in Aortic Dissection Trial
[ Fri, Aug 06th 2010 ] - Market Wire
Cardiovascular Systems to Webcast Fiscal 2010 Fou .. -Year Earnings Conference Call Tuesday, August 10
[ Fri, Aug 06th 2010 ] - Market Wire
Aetna Announces Expanded Support of Health Information Technology
[ Fri, Aug 06th 2010 ] - Market Wire
Alkermes Reports First Quarter Fiscal 2011 Financial Results
[ Fri, Aug 06th 2010 ] - Market Wire
Ironwood Pharmaceuticals Provides Second Quarter 2010 Investor Update
[ Fri, Aug 06th 2010 ] - Market Wire
Exelixis Announces Second Quarter 2010 Financial Results
[ Fri, Aug 06th 2010 ] - Market Wire
Cooper Announces Release Date for Third Quarter 2010
[ Fri, Aug 06th 2010 ] - Market Wire
RXi Pharmaceuticals to Host Second Quarter 2010 Conference Call on Wednesday, August 11, 2010
[ Fri, Aug 06th 2010 ] - Market Wire
InSite Vision Reports Second Quarter 2010 Financial Results
[ Fri, Aug 06th 2010 ] - Market Wire
Exelixis Announces August 12 Webcast of Presentat .. e Canaccord Genuity 30th Annual Growth Conference
[ Fri, Aug 06th 2010 ] - Market Wire
Micromet Reports Second Quarter 2010 Financial Results
[ Fri, Aug 06th 2010 ] - Market Wire
Inspire Announces Webcast of Presentation at Bank .. errill Lynch Specialty Pharmaceuticals Conference

Inspire Announces Webcast of Presentation at Bank of America Merrill Lynch Specialty Pharmaceuticals Conference


Published on 2010-08-06 04:26:42 - Market Wire
  Print publication without navigation


DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Adrian Adams, President and CEO, will present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Thursday, August 12, 2010 at 3:40 pm ET in Southampton, NY.

The webcast of the presentation will be available on Inspire's web site at [ www.inspirepharm.com ]. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspirea™s goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical, scientific and commercial expertise. The most advanced compounds in Inspirea™s clinical pipeline are denufosol tetrasodium for cystic fibrosis and PROLACRIAa" (diquafosol tetrasodium ophthalmic solution) 2% for dry eye, which are both in Phase 3 development, and AZASITE®(azithromycin ophthalmic solution) 1% for blepharitis, which is in Phase 2 development. Inspire receives revenues related to the promotion of AZASITE for bacterial conjunctivitis, the co-promotion of ELESTAT® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and royalties based on net sales of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. For more information, visit [ www.inspirepharm.com ].

Contributing Sources